Skip to content
Disclosery

ORBIMED ADVISORS LLC: TMO position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on TMO, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 90,700 TMO shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 90,700 shares
    Change vs previous 13F +44,200 shares

    0.86% of the 13F portfolio, value $45,473,352.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 46,500 shares
    Change vs previous 13F 0 shares

    0.5% of the 13F portfolio, value $22,856,145.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 46,500 shares
    Change vs previous 13F 0 shares

    0.55% of the 13F portfolio, value $26,944,425.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 46,500 shares
    Change vs previous 13F 0 shares

    0.54% of the 13F portfolio, value $22,553,430.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 46,500 shares
    Change vs previous 13F -82,500 shares

    0.47% of the 13F portfolio, value $18,853,890.

    13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 129,000 shares
    Change vs previous 13F +44,600 shares

    1.54% of the 13F portfolio, value $64,190,400.

    13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 84,400 shares
    Change vs previous 13F 0 shares

    0.91% of the 13F portfolio, value $43,907,412.

    13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 84,400 shares
    Change vs previous 13F not available

    0.96% of the 13F portfolio, value $52,207,308.

    13F-HR 0001172661-24-005167 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).